Some studies found Bcl-2 protein and c-Myc co-expression to be an independent risk factor indicating worse outcomes in DLBCL [13,14], but it might be related to the fact that c-Myc-positive DLBCL usually has a high Ki67 index as noted in our study. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.